40.45
price up icon1.15%   0.46
pre-market  Pre-mercato:  41.45   1.00   +2.47%
loading
Precedente Chiudi:
$39.99
Aprire:
$39.99
Volume 24 ore:
413.30K
Relative Volume:
0.64
Capitalizzazione di mercato:
$1.73B
Reddito:
$17.39M
Utile/perdita netta:
$-135.89M
Rapporto P/E:
-8.7177
EPS:
-4.64
Flusso di cassa netto:
$-123.00M
1 W Prestazione:
+0.62%
1M Prestazione:
-7.75%
6M Prestazione:
-26.65%
1 anno Prestazione:
+46.82%
Intervallo 1D:
Value
$39.40
$41.06
Intervallo di 1 settimana:
Value
$39.19
$41.50
Portata 52W:
Value
$20.08
$57.28

Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile

Name
Nome
Tarsus Pharmaceuticals Inc
Name
Telefono
(949) 409-9820
Name
Indirizzo
15440 LAGUNA CANYON ROAD, IRVINE
Name
Dipendente
323
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
TARS's Discussions on Twitter

Confronta TARS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TARS
Tarsus Pharmaceuticals Inc
40.45 1.73B 17.39M -135.89M -123.00M -4.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-02 Ripresa Oppenheimer Outperform
2025-05-27 Ripresa H.C. Wainwright Buy
2023-11-20 Iniziato Goldman Neutral
2023-07-18 Iniziato William Blair Outperform
2023-05-18 Iniziato Guggenheim Buy
2022-08-01 Iniziato Barclays Overweight
2021-12-21 Iniziato H.C. Wainwright Buy
2021-11-23 Iniziato Oppenheimer Outperform
2020-11-10 Iniziato BofA Securities Buy
2020-11-10 Iniziato Jefferies Buy
2020-11-10 Iniziato Ladenburg Thalmann Buy
2020-11-10 Iniziato Raymond James Strong Buy
Mostra tutto

Tarsus Pharmaceuticals Inc Borsa (TARS) Ultime notizie

pulisher
Jun 18, 2025

Tarsus Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 17, 2025

Tarsus Pharmaceuticals Becomes Oversold (TARS) - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

When (TARS) Moves Investors should Listen - news.stocktradersdaily.com

Jun 17, 2025
pulisher
Jun 17, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Rhumbline Advisers Increases Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Jun 16, 2025
pulisher
Jun 12, 2025

Tarsus Pharmaceuticals’ SWOT analysis: XDEMVY’s success propels stock growth - Investing.com Australia

Jun 12, 2025
pulisher
Jun 12, 2025

Tarsus Pharmaceuticals’ SWOT analysis: XDEMVY’s success propels stock growth By Investing.com - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

Insider Sell: Aziz Mottiwala Sells 17,500 Shares of Tarsus Pharm - GuruFocus

Jun 12, 2025
pulisher
Jun 11, 2025

Tarsus Pharmaceuticals CCO sells $765,800 in stock - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

Tarsus Pharmaceuticals CCO sells $765,800 in stock By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 10, 2025

Certain Common stock of Tarsus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 11-JUN-2025. - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Certain Stock Options of Tarsus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 11-JUN-2025. - MarketScreener

Jun 10, 2025
pulisher
Jun 09, 2025

Tarsus Pharmaceuticals at Goldman Sachs Conference: Strategic Growth Focus By Investing.com - Investing.com Canada

Jun 09, 2025
pulisher
Jun 09, 2025

Transcript : Tarsus Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 01 - MarketScreener

Jun 09, 2025
pulisher
Jun 08, 2025

Stocks Showing Improving Market Leadership: Tarsus Pharmaceuticals Earns 87 RS Rating - MSN

Jun 08, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Sells 51,329 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Jun 07, 2025
pulisher
Jun 04, 2025

Where are the Opportunities in (TARS) - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 03, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Now Covered by Oppenheimer - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Oppenheimer Adjusts Price Target on Tarsus Pharmaceuticals to $75 From $72, Maintains Outperform Rating - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

TARS: Oppenheimer Ups Tarsus Pharmaceuticals Price Target to $75 | TARS Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

TARS: Oppenheimer Ups Tarsus Pharmaceuticals Price Target to $75 - GuruFocus

Jun 02, 2025
pulisher
May 30, 2025

What is HC Wainwright’s Estimate for TARS Q2 Earnings? - Defense World

May 30, 2025
pulisher
May 30, 2025

Nuveen Asset Management LLC Sells 15,186 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

May 30, 2025
pulisher
May 29, 2025

Tarsus to Participate in Upcoming Investor Conferences | TARS Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Tarsus Lines Up Triple Conference Appearances: William Blair, Jefferies, and Goldman Sachs in June - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire

May 29, 2025
pulisher
May 29, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Purchased by Ameriprise Financial Inc. - Defense World

May 29, 2025
pulisher
May 28, 2025

BNP Paribas Financial Markets Buys New Shares in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

May 28, 2025
pulisher
May 28, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Rating Upgraded by HC Wainwright - Defense World

May 28, 2025
pulisher
May 28, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Now Covered by HC Wainwright - Defense World

May 28, 2025
pulisher
May 28, 2025

TARS: HC Wainwright & Co. Initiates Buy Rating with $72 Target | - GuruFocus

May 28, 2025
pulisher
May 27, 2025

Tarsus Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

May 27, 2025
pulisher
May 27, 2025

TARS: HC Wainwright & Co. Initiates Buy Rating with $72 Target | TARS Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

TARS: H.C. Wainwright Initiates Coverage with a Buy Rating | TARS Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Tarsus Pharmaceuticals Advances Novel Treatments for Eye and Vector-Borne Diseases - utahdailynewswire.com

May 27, 2025
pulisher
May 26, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $1.16 Million Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

May 26, 2025
pulisher
May 23, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Recommendation of “Buy” from Brokerages - Defense World

May 23, 2025
pulisher
May 21, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Purchased by Bank of America Corp DE - Defense World

May 21, 2025
pulisher
May 20, 2025

Tarsus Pharmaceuticals at H.C. Wainwright: Expanding Horizons with Xdemvy By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 19, 2025

Tarsus Pharmaceuticals Shows Rising Price Performance With Jump To 84 RS Rating - inkl

May 19, 2025
pulisher
May 14, 2025

When the Price of (TARS) Talks, People Listen - news.stocktradersdaily.com

May 14, 2025
pulisher
May 14, 2025

Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Tarsus Pharmaceuticals Inc Enters Oversold Territory (TARS) - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Acquired by Northern Trust Corp - Defense World

May 14, 2025
pulisher
May 14, 2025

Transcript : Tarsus Pharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 03 - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

Tarsus Pharmaceuticals Breaks Below 200-Day Moving AverageNotable for TARS - Nasdaq

May 13, 2025
pulisher
May 13, 2025

Tarsus Pharmaceuticals (TARS) Expected to Announce Earnings on Wednesday - Defense World

May 13, 2025
pulisher
May 12, 2025

Tarsus Pharmaceuticals: The "Get Big Fast" Approach Could Pay Off (NASDAQ:TARS) - Seeking Alpha

May 12, 2025
pulisher
May 08, 2025

Tarsus to Participate in Upcoming Investor Conferences | TARS St - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Dimensional Fund Advisors LP Sells 62,658 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

May 08, 2025
pulisher
May 07, 2025

Tarsus Pharmaceuticals Reports First Quarter 2025 Sales Growth - VisionMonday.com

May 07, 2025

Tarsus Pharmaceuticals Inc Azioni (TARS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):